UK markets closed

Ultimovacs ASA (ULTI.OL)

Oslo - Oslo Delayed price. Currency in NOK
Add to watchlist
6.93-0.65 (-8.58%)
At close: 04:29PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
123,834
123,834
95,175
96,735
64,660
Selling general and administrative
6,476
6,476
9,246
5,061
3,978
Total operating expenses
215,734
215,734
183,630
163,832
124,146
Operating income or loss
-215,734
-215,734
-183,630
-163,832
-124,146
Interest expense
-
-
-
333
240
Income before tax
-189,239
-189,239
-167,792
-164,722
-120,552
Income tax expense
0
0
0
0
0
Income from continuing operations
-189,239
-189,239
-167,792
-164,722
-120,552
Net income
-189,239
-189,239
-167,792
-164,722
-120,552
Net income available to common shareholders
-189,239
-189,239
-167,792
-164,722
-120,552
Basic EPS
-6.00
-
-4.90
-5.10
-4.00
Diluted EPS
-6.00
-
-4.90
-5.10
-4.00
Basic average shares
34,374
-
34,247
32,373
30,260
Diluted average shares
34,374
-
34,247
32,373
30,260